title: Effects of eight weeks of caffeine supplementation and endurance training on aerobic fitness and body composition.
abstract: The purpose of this study was to examine the effects of daily administration of a supplement that contained caffeine in conjunction with 8 weeks of aerobic training on VO(2)peak, time to running exhaustion at 90% VO(2)peak, body weight, and body composition. Thirty-six college students (14 men and 22 women; mean +/- SD, age 22.4 +/- 2.9 years) volunteered for this investigation and were randomized into either a placebo (n = 18) or supplement group (n = 18). The subjects ingested 1 dose (3 pills = 201 mg of caffeine) of the placebo or supplement per day during the study period. In addition, the subjects performed treadmill running for 45 minutes at 75% of the heart rate at VO(2)peak, three times per week for 8 weeks. All subjects were tested pretraining and posttraining for VO(2)peak, time to running exhaustion (TRE) at 90% VO(2)peak, body weight (BW), percentage body fat (%FAT), fat weight (FW), and fat-free weight (FFW). The results indicated that there were equivalent training-induced increases (p < 0.05) in VO(2)peak and TRE for the supplement and placebo groups, but no changes (p > 0.05) in BW, %FAT, FW, or FFW for either group. These findings indicated that chronic use of the caffeine-containing supplement in the present study, in conjunction with aerobic training, provided no ergogenic effects as measured by VO(2)peak and TRE, and the supplement was of no benefit for altering body weight or body composition.
authors.affiliation: University of Nebraska-Lincoln Human Performance Laboratory, Department of Nutrition and Health Sciences, Lincoln, NE 68583, USA. mmalek@unlserve.unl.edu
authors.forename: Moh H
authors.initials: MH
authors.lastname: Malek
authors.forename: Terry J
authors.initials: TJ
authors.lastname: Housh
authors.forename: Jared W
authors.initials: JW
authors.lastname: Coburn
authors.forename: Travis W
authors.initials: TW
authors.lastname: Beck
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Schmidt
authors.forename: Dona J
authors.initials: DJ
authors.lastname: Housh
authors.forename: Glen O
authors.initials: GO
authors.lastname: Johnson
mesh_terms: D000284:Administration, Oral; D000328:Adult; D015308:Anaerobic Threshold / Q000187:drug effects* / Q000502:physiology; D000704:Analysis of Variance; D001823:Body Composition / Q000187:drug effects* / Q000502:physiology; D002110:Caffeine / Q000008:administration & dosage / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D019587:Dietary Supplements; D005260:Female; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects / Q000502:physiology; D010807:Physical Endurance / Q000187:drug effects* / Q000502:physiology; D010809:Physical Fitness / Q000502:physiology*; D012420:Running / Q000502:physiology
chemical_list: D000697:Central Nervous System Stimulants; D002110:Caffeine